OLD National Bancorp IN Sells 1,061 Shares of Intuitive Surgical, Inc. $ISRG

OLD National Bancorp IN decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.9% in the 3rd quarter, HoldingsChannel reports. The fund owned 4,882 shares of the medical equipment provider’s stock after selling 1,061 shares during the period. OLD National Bancorp IN’s holdings in Intuitive Surgical were worth $2,183,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently modified their holdings of ISRG. Brighton Jones LLC raised its stake in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. Axiom Investors LLC DE bought a new stake in Intuitive Surgical in the 1st quarter valued at $76,559,000. Campbell & CO Investment Adviser LLC raised its stake in shares of Intuitive Surgical by 125.4% in the 1st quarter. Campbell & CO Investment Adviser LLC now owns 3,778 shares of the medical equipment provider’s stock valued at $1,871,000 after buying an additional 2,102 shares in the last quarter. Synovus Financial Corp lifted its holdings in shares of Intuitive Surgical by 36.9% during the 1st quarter. Synovus Financial Corp now owns 3,492 shares of the medical equipment provider’s stock worth $1,729,000 after acquiring an additional 941 shares during the period. Finally, J. Stern & Co. LLP acquired a new stake in shares of Intuitive Surgical during the 1st quarter valued at about $2,363,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on ISRG shares. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Evercore ISI upped their price objective on Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Friday, October 24th. The Goldman Sachs Group boosted their price target on Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $611.08.

Intuitive Surgical Price Performance

Shares of ISRG opened at $577.34 on Wednesday. The company has a market capitalization of $206.96 billion, a P/E ratio of 76.37, a PEG ratio of 5.33 and a beta of 1.68. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The business’s 50 day simple moving average is $547.18 and its 200-day simple moving average is $505.91.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business’s revenue was up 22.9% on a year-over-year basis. During the same period last year, the firm posted $1.84 EPS. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In related news, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the transaction, the executive vice president directly owned 3,056 shares of the company’s stock, valued at $1,772,480. The trade was a 81.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Mark Brosius sold 464 shares of the company’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $548.49, for a total transaction of $254,499.36. Following the transaction, the senior vice president owned 131 shares in the company, valued at approximately $71,852.19. This trade represents a 77.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 114,007 shares of company stock valued at $63,533,844 in the last 90 days. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.